Innovation at Eurofarma: Transforming Healthcare with Global Reach

Innovation is the driving force behind Eurofarma’s continuous evolution. Guided by science and a commitment to creating a real and positive impact on patients’ quality of life, we have built one of the most robust healthcare innovation platforms in Latin America. As pioneers in adopting new technologies, we continue to expand our boundaries with a truly global reach, ensuring that cutting-edge pharmaceutical development efficiently reaches those who need it most.

Our strategic vision is brought to life through an ecosystem focused on four key pillars:

• Radical Innovation: Discovery and development of novel medicines designed to deliver impact on a global scale.
• Incremental Innovation: Creation of new pharmaceutical forms and smart combinations that enhance efficacy, safety, and the patient experience.
• High-Quality Generic Medicines: Continuous application of technological innovation to maximize the efficiency of development projects, ensuring broad access to healthcare with excellence and quality.
• Open Innovation and Strategic Partnerships: We believe science knows no borders. We work through a dynamic network of global experts, connecting top talent from industry and academia across Brazil, Latin America, and the world. This collaboration is central to our innovation strategy, accelerating the development of new therapies and enabling access to global innovation for our populations.
• Digital Acceleration and Competitiveness: We adopt new digital technologies throughout every stage of the innovation cycle. Data science, automation, and artificial intelligence are not merely tools, but essential accelerators that support research activities, process optimization, and fast, accurate decision-making.
  These initiatives directly increase the speed and efficiency of our programs, reinforcing our competitiveness.

At Eurofarma, innovation goes beyond physical boundaries and permeates the entire organization. Guided by the strategic leadership of our Innovation area, this culture is reflected in a broad, dynamic, and borderless ecosystem. Our activities encompass integrated infrastructures not only across Brazil and Latin America, but also through a strong external innovation network and global collaborations. This extensive reach allows us to access and develop the most advanced scientific breakthroughs worldwide.

Eurolab, inaugurated in 2020, is the epicenter of innovation and home to one of the largest pharmaceutical R&D centers in Latin America. Within this state-of-the-art facility, equipped with advanced analytical, research, and pilot manufacturing laboratories, the tangible development of our new medicines and dietary supplements takes place. Eurolab’s world-class infrastructure transforms scientific knowledge generated across our network into real products, delivering quality, efficiency, and high-value solutions to patients and healthcare professionals.

Our Future More than developing medicines, Eurofarma aims to lead the next generation of healthcare innovation by combining scientific excellence, emerging technologies, and our extensive network of global partners. By deeply understanding patients’ needs, we transform today’s greatest healthcare challenges into opportunities for positive impact on tomorrow’s society.